{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T05:11:25Z","timestamp":1755925885651},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UO1-AI56580"],"award-info":[{"award-number":["UO1-AI56580"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.vaccine.2014.11.042","type":"journal-article","created":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T06:40:46Z","timestamp":1417329646000},"page":"430-436","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax"],"prefix":"10.1016","volume":"33","author":[{"given":"Jon","family":"Oscherwitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemp B.","family":"Cease","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.11.042_bib0005","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.1834478100","article-title":"A dually active anthrax vaccine that confers protection against both bacilli and toxins","volume":"100","author":"Rhie","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/mt.2008.242","article-title":"Genetic vaccines for anthrax based on recombinant adeno-associated virus vectors","volume":"17","author":"Liu","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0015","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.vaccine.2003.09.043","article-title":"Genetic immunization against anthrax","volume":"22","author":"Galloway","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa0810603","article-title":"Raxibacumab for the treatment of inhalational anthrax","volume":"361","author":"Migone","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbiotec.2014.01.033","article-title":"Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine","volume":"176","author":"Gorantala","year":"2014","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0030","doi-asserted-by":"crossref","first-page":"18091","DOI":"10.1073\/pnas.1013083107","article-title":"Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities","volume":"107","author":"Merkel","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0035","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/IAI.00358-09","article-title":"Synthetic peptide vaccine targeting a cryptic neutralizing epitope in domain 2 of Bacillus anthracis protective antigen","volume":"77","author":"Oscherwitz","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1128\/CVI.00612-12","article-title":"Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthrax","volume":"20","author":"Oscherwitz","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin","volume":"19","author":"Collier","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0050","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase\u2013kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0055","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0060","doi-asserted-by":"crossref","first-page":"22090","DOI":"10.1074\/jbc.M010222200","article-title":"A dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin action in vivo","volume":"276","author":"Singh","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0065","doi-asserted-by":"crossref","first-page":"29039","DOI":"10.1016\/S0021-9258(19)62010-7","article-title":"The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor","volume":"269","author":"Singh","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0070","doi-asserted-by":"crossref","first-page":"30936","DOI":"10.1074\/jbc.M301154200","article-title":"Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody","volume":"278","author":"Rosovitz","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/15321810701454706","article-title":"Development of a competitive enzyme linked immunosorbent assay to identify epitope specific antibodies in recipients of the U.S. licensed anthrax vaccine","volume":"28","author":"Gubbins","year":"2007","journal-title":"J Immunoassay Immunochem"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0080","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1128\/IAI.01151-06","article-title":"A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge","volume":"74","author":"Calvo-Calle","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0085","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1073\/pnas.85.15.5409","article-title":"Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system","volume":"85","author":"Tam","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0090","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.4049\/jimmunol.1001749","article-title":"A synthetic peptide vaccine directed against the 2\u03b22-2\u03b23 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax","volume":"185","author":"Oscherwitz","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0095","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/intimm\/3.10.997","article-title":"Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein","volume":"3","author":"Moreno","year":"1991","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0100","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1128\/IAI.00899-09","article-title":"A heterologous helper T-cell epitope enhances the immunogenicity of a multiple-antigenic-peptide vaccine targeting the cryptic loop-neutralizing determinant of Bacillus anthracis protective antigen","volume":"77","author":"Oscherwitz","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0105","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/eji.1830191209","article-title":"Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells","volume":"19","author":"Panina-Bordignon","year":"1989","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0110","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4049\/jimmunol.149.2.717","article-title":"Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination","volume":"149","author":"Valmori","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0115","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0120","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1016\/S0264-410X(03)00437-7","article-title":"Safety and efficacy of CpG-containing oligodeoxynucleotides as immunological adjuvants in rabbits","volume":"21","author":"Ioannou","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biologicals.2003.09.003","article-title":"Validation of the anthrax lethal toxin neutralization assay","volume":"32","author":"Hering","year":"2004","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0130","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1084\/jem.168.6.2091","article-title":"Mechanisms influencing the immunodominance of T cell determinants","volume":"168","author":"Adorini","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0135","doi-asserted-by":"crossref","first-page":"13601","DOI":"10.1073\/pnas.0405557101","article-title":"A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores","volume":"101","author":"Hermanson","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0140","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1128\/AEM.00369-08","article-title":"Identification and characterization of Bacillus anthracis spores by multiparameter flow cytometry","volume":"74","author":"Schumacher","year":"2008","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0145","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.micpath.2005.02.001","article-title":"The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions","volume":"38","author":"Cote","year":"2005","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0155","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1016\/j.vaccine.2005.12.028","article-title":"Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine","volume":"24","author":"Little","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0160","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0165","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1128\/IAI.00072-10","article-title":"An epitope of Bacillus anthracis protective antigen that is cryptic in rabbits may be immunodominant in humans","volume":"78","author":"Ingram","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/nat.2012.0340","article-title":"CpG still rocks! Update on an accidental drug","volume":"22","author":"Krieg","year":"2012","journal-title":"Nucl Acid Ther"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0175","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.20052433","article-title":"Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates","volume":"203","author":"Wille-Reece","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0180","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.vaccine.2009.01.094","article-title":"A single-dose combination therapy that both prevents and treats anthrax infection","volume":"27","author":"Klinman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0185","doi-asserted-by":"crossref","first-page":"151ra26","DOI":"10.1126\/scitranslmed.3004073","article-title":"Anthrax vaccine-induced antibodies provide cross-species prediction of survival to aerosol challenge","volume":"4","author":"Fay","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0190","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1128\/IAI.01254-08","article-title":"Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed","volume":"77","author":"Reason","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.11.042_bib0195","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1016\/j.vaccine.2008.05.023","article-title":"Domain specificity of the human antibody response to Bacillus anthracis protective antigen","volume":"26","author":"Reason","year":"2008","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14015953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14015953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T10:01:07Z","timestamp":1690711267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14015953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0264410X14015953"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.11.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}